INTRODUCTION
True villous adenomas of the papillae of Vater are rare. It was as late as 1895 that Calzavara first described a benign ampullary papilloma of the papillae of Vater [1] . The clinical diagnosis of ampullary adenoma was uncommon before 1973, since which time ERCP has become widely used in the diagnosis of pancreaticobiliary diseases. With the increasing use of ERCP, adenomas of the papilla have been detected more often by a lateral duodenoscopy [2, 3] .
The differentiation between a benign adenoma and an infiltrating carcinoma based on endoscopic specimens may be difficult [4] . It has also become evident that adenomas of the papilla are precancerous lesions [4] [5] [6] . The first transduodenal excision of an ampullary tumour was performed by Halsted in 1897 [7] . After that, local excision became the most common procedure for the treatment of ampullary tumours, with at least 85 cases reported by 1935 [8] .
When Whipple introduced pancreaticoduodenectomy for the treatment of pancreatic and periampullary tumours in 1935, local excision was relegated to the background. Recently, a new *Address for correspondence: Department of Surgery, Division of Gastroenterology, Oulu University Hospital, Kajaanintie 50, FIN-90220 Oulu, Finland. interest in the local treatment of ampullary lesions has arisen, and it has been suggested that ampullary excision is still useful [9] . Eleven [10] , and these tumours are only visualized and biopsy specimens can only be taken after papillotomy [11] . Two of our patients had a smooth-lined defect in the distal choledochus, and both of these tumours were only visualized after papillotomy.
After ERCP was introduced on a large scale, increasing numbers of adenomas of the papillae There is significant evidence to suggest-that adenoma of the papillae of Vater is a precancerous lesion [4, 5] similarly to adenoma of the colon and should be treated accordingly. Endoscopic biopsy of adenomas is unreliable in showing the carcinomatous foci in an adenomatous tumour [12] . The malignant potential of these adenomas was shown by one of our own patients, who was treated conservatively (81-year-old male with aortic stenosis). He was followed up with repeated endoscopic biopsies, and endoprosthesis was used to treat bile and pancreatic duct stenosis. In spite of intense local follow-up, adenocarcinoma of the distal choledochus with hepatic metastases developed one and a half years after the diagnosis, and the patient needed urgent surgery for acute cholecystitis. The unreliability of endoscopic biopsies in detecting malignancy was shown by one female patient subjected to extensive local excision Histological specimens showed in this tumour a 2-cm-wide malignant lesion, which, however, was removed with clear operative margins.
The adenoma of the papillae Vater presents also a therapeutic dilemma. While there is a uniform agreement that these lesions should be resected, opinions differ as to the method of resection, ranging from endoscopic treatment [13] to radical pancreaticoduodenectomy [14] [15] [16] . The local excision, although generally associated with lower morbidity has a higher recurrence rate [13, [17] [18] [19] . The recurrence can occur with or without malignant transformation [20] . The recurrence rate must be weighted against the potential operative mortality and morbidity rates for pancreaticoduodenectomy. According to recent series [2, 11, 21] as well as our own series the transduodenal excision is safe and could be ideal in selected patients with high operative risk for pancreaticoduodenectomy.
During the past decade several reports have advocated local ampullary resection also for selected patients with malignant lesions [12] . Although the comparison of local excision and pancreaticoduodenectomy is impossible because of selection bias [12, 17] , excellent results with long-term survivors after local excision for cancer have been reported [18, [22] [23] [24] [25] .
The technique of transduodenal excision of ampullary tumours has received little attention [9, 11] . According to our experience, preoperative cannulation of the bile duct and if possible pancreatic duct, helps us to localize the walls of these ducts at operation. The possibility to excise the mucosa against the prosthesis is also a definite advantage. Unfortunately technical difficulties caused by the tumour often prevents cannulation.
The localization of the pancreatic duct is often difficult during operation. Secretin can be used to stimulate pancreatic secretion to help to identify the pancreatic duct orifice [9] . The reconstruction is critical to ensure adequate biliary and pancreatic drainage and to prepare the transduodenal defect. Loupe magnification is rather useful for accurate reconstruction [19] and our experience in two last patients confirm this. T-tube drainage through the choledochotomy or stents through the anastomosis to the duodenum have been used but their usage is obviously not obligatory.
Two of our patients have been followed for 12 and 13 years, respectively, without any recurrence. In two of our patients the initial treatment was snare fulguration, but a recurrence developed in both cases within a year. For this reason we have abondoned this approach in favour of local transduodenal excision. The treatment of recurrent disease can be problematic. Some patients with benign small recurrences can be treated by local excision [19] , but pancreaticoduodenectomy should be considered whenever possible. A re-excision was necessary for one of outpatients 18 months after the primary operation. The re-excision lead to narrowing of the duodenum, requiring a gastrojejunostomy which should be considered as a prophylactic procedure, if a local excision is chosen for reoperation instead of pancreaticoduodenectomy.
In conclusion, transduodenal excision of ampullary tumour is technically safe and indicated in selected patients with high operative risk. The recurrence rate needs to be evaluated after longer follow-up.
